The FDA has approved a new prefilled syringe formulation for Roche’s asthma drug Xolair, as the Swiss company aims to prolong its shelf life. Xolair (omalizumab) generated revenues of more than ...

FDA approved Vyvgart Hytrulo prefilled syringe for gMG and CIDP self-injection in 20–30 seconds. Human factor studies showed patients and caregivers safely administered the new formulation.

The global prefilled syringes market share is projected to grow from US$ 6.69 Billion in 2022 to US$ 15.0 Billion by 2030, driven by the increasing prevalence of chronic diseases and rising demand ...

The primary endpoint was the change from baseline in weekly itch severity score (ISS7) at week 12. Findings at week 12 showed equivalent efficacy for the primary endpoint between omalizumab-igec 300mg ...

The primary endpoint was the change from baseline in weekly itch severity score (ISS7) at week 12. Findings at week 12 showed equivalent efficacy for the primary endpoint between omalizumab-igec 300mg ...

During the first period, study participants (N=619) were randomly assigned to receive omalizumab-igec 300mg, Xolair 300mg, omalizumab-igec 150mg, or Xolair 150mg for 12 weeks.

The new single-dose prefilled syringes will be available in 40 USP units/0.5mL and 80 USP units/mL dosage strengths. Cortrophin Gel will also continue to be supplied in 5mL (400 USP units/5mL) and ...

For children 12 years of age and older, XOLAIR prefilled syringe or autoinjector may be self-injected under adult supervision. For children 1 to 11 years of age, XOLAIR prefilled syringe should be ...

The single-dose prefilled syringe contains 200mg/mL of testosterone cypionate, the oil-soluble 17 (beta)-cyclopentylpropionate ester of the androgenic hormone testosterone.